shot-button
Subscription Subscription
Home > Lifestyle News > Health And Fitness News > Article > Study links Covid infection with increased risk of schizophrenia

Study links Covid infection with increased risk of schizophrenia

Updated on: 06 January,2024 11:03 PM IST  |  New York
IANS |

Schizophrenia is a serious mental condition characterised by hallucinations, delusions and other cognitive impairments

Study links Covid infection with increased risk of schizophrenia

Image for representational purpose only. Photo Courtesy: istock

Even as the world is seeing a fresh surge in Covid-19 cases, a new study has shown an association between SARS-CoV-2 infections and the onset of mental health disorders like schizophrenia.


Schizophrenia is a serious mental condition characterised by hallucinations, delusions and other cognitive impairments.


Previous research suggests it may be triggered by viruses, such as the flu or even Covid-19.


The new study, not peer-reviewed yet, found a substantial increase in the likelihood of being diagnosed with a schizophrenia spectrum and psychotic disorder (SSPD) after experiencing moderate to severe illness due to SARS-CoV-2 infection, in comparison to a group of individuals who had non-Covid Acute Respiratory Distress Syndrome (ARDS).

“Our study is consistent with the known neurotropism of the SARS-CoV-2 virus and other reports of increased risk of major psychiatric disorders following Covid-19 infection,” said Asif Rahman, from the Department of Industrial & Management Systems Engineering, West Virginia University.

“Further research is required to identify specific characteristics of populations and individuals who may be at a particularly high risk of developing SSPD and potentially other significant psychiatric conditions following Covid-19 infection. Understanding these psychiatric risks associated with Covid-19 is an essential component of our strategy to address the evolving landscape of long-Covid,” added Rahman, in the paper posted on a preprint site.

Different from other studies, the team took acute respiratory distress syndrome (ARDS) and Covid-19 lab negative cohorts as control groups to accurately gauge the impact of Covid-19 on SSPD.

Data from 19,344,698 patients were methodically filtered to create propensity matched cohorts: ARDS, Covid-positive, and Covid-negative.

They analysed the hazard rate of new-onset SSPD across three distinct time intervals: 0-21 days, 22-90 days, and beyond 90 days post-infection.

Covid-19 positive patients consistently exhibited a heightened hazard ratio across all intervals, the findings showed.

“These are notably higher than both ARDS and Covid-19 lab-negative patients,” the team said.

“Intriguingly, our data indicated that younger individuals face a heightened risk of SSPD after contracting Covid-19, a trend not observed in the ARDS and Covid-negative groups,” they added.

The study underscores the vital importance of keeping a close watch on the mental well-being of those recovering from Covid-19. Their persistent increased risk points to a wider societal concern, especially regarding severe psychiatric conditions like SSPD.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK